文献速递其他结缔组织病

CD19靶向嵌合抗原受体T细胞清除B细胞在系统性硬化症小鼠模型中的作用

Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2023-11-27

在模拟系统性硬化症严重肺损伤的Fra-2转基因小鼠模型中,评估抗CD20单克隆抗体单药与CD19靶向CAR-T细胞联合抗CD20单克隆抗体两种B细胞清除策略的耐受性和疗效。联合治疗在外周血和病变肺中实现更深B细胞清除,但加重临床评分、增加死亡率,并显著增加肺胶原含量、组织学纤维化评分和右心室收缩压;抗CD20单药对肺炎症驱动纤维化和肺动脉高压无影响。

要点

  • CD19靶向CAR-T联合抗CD20单克隆抗体较抗CD20单药在外周血和病变肺中B细胞清除更深。
  • CAR-T细胞输注加重Fra-2转基因小鼠临床评分并增加死亡率。
  • CAR-T输注显著增加肺胶原含量、组织学纤维化评分和右心室收缩压。

核心结论

  • B细胞疗法在Fra-2转基因小鼠中未能显示疗效。
  • 加重的Fra-2肺炎症负荷刺激活化CD19靶向CAR-T细胞积聚和扩增,继发T细胞活化和全身炎症,最终导致疾病恶化。

研究设计与样本

  • 在Fra-2转基因小鼠模型中进行临床前研究,评估两种B细胞清除策略的耐受性和疗效。
  • 第一组为16只未治疗小鼠。
  • 第二组为15只接受单剂抗CD20单克隆抗体治疗的小鼠。
  • 第三组为8只接受CD19靶向CAR-T细胞联合抗CD20单克隆抗体治疗的小鼠。
  • 经过六周临床评估后,检测炎症、肺纤维化和肺血管重塑的不同经验证标志物。

主要发现

  • CD19靶向CAR-T细胞联合抗CD20单克隆抗体在外周血和病变肺中较抗CD20单克隆抗体单药实现更深的B细胞清除。
  • CAR-T细胞输注加重Fra-2转基因小鼠的临床评分并增加死亡率。
  • CAR-T细胞输注显著增加肺胶原含量、组织学纤维化评分和右心室收缩压。
  • CAR-T细胞在病变肺中积聚并促进T细胞活化和炎性细胞因子产生。
  • 抗CD20单克隆抗体单药治疗对肺炎症驱动纤维化和肺动脉高压无影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our goal was to study the tolerance and efficacy of two B cell depletion strategies, including one with CD19-targeted chimeric antigen receptor (CAR) T cells, in a preclinical model mimicking the severe lung damages observed in systemic sclerosis. METHODS: B cell depletion strategies were evaluated in the Fra-2 transgenic (Tg) mouse model. We considered a first group of 16 untreated mice, a second group of 15 mice receiving a single dose of anti-CD20 monoclonal antibody (mAb), and a third group of 8 mice receiving CD19-targeted CAR-T cells in combination with anti-CD20 monoclonal antibody. After six weeks of clinical evaluation, different validated markers of inflammation, lung fibrosis, and pulmonary vascular remodeling were assessed. RESULTS: CD19-targeted CAR-T cells infusion in combination with anti-CD20 mAb resulted in a deeper B cell depletion than anti-CD20 mAb alone in the peripheral blood and lesional lungs of Fra-2 Tg mice. CAR-T cell infusion worsened the clinical score and increased mortality in Fra-2 Tg mice. In line with the above findings, CAR-T cell infusion significantly increased lung collagen content, the histological fibrosis score, and right ventricular systolic pressure. CAR-T cells accumulated in lesional lungs and promoted T activation and inflammatory cytokine production. Treatment with anti-CD20 mAb in monotherapy had no impact on lung inflammation-driven fibrosis and pulmonary hypertension. CONCLUSION: B cell therapies failed to show efficacy in the Fra2 Tg mice. The exacerbated Fra-2 lung inflammatory burden stimulated accumulation and expansion of activated CD19-targeted CAR-T cells, secondarily inducing T cell activation and systemic inflammation, finally leading to disease worsening.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Avouac J, Cauvet A, Orvain C, et al. Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis. Arthritis Rheumatol. 2023. PMID: 37610259. doi:10.1002/art.42677

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。